In partnership with Alzheimer's Society and the British Heart Foundation, we are delighted to announce our funding of three new awards in vascular dementia research. This constitutes a combined investment of £2.2 million into a key area of unmet need.
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
About 80% of strokes are caused by a blocked blood vessel. One third of these patients have a blockage of a large blood vessel in the neck or brain known as large artery occlusion stroke (LAOS).
As part of our research programme, we fund exceptional candidates from stroke professional backgrounds to our prestigious Postgraduate and Postdoctoral Fellowship positions. Meet our new fellows for 2017.
Vascular dementia is the 2nd leading cause of dementia in the UK and there are currently no proven treatments. A new study at the University of Southampton is now investigating whether a failure of fluid drainage along the walls of blood vessels in the brain is a cause of vascular dementia.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC), which is the national membership organisation of leading medical and health research charities in the UK. Published today, the AMRC's 'Making a difference: Impact report 2017' highlights how the research of its member charities makes a difference.
President of the Stroke Alliance for Europe (SAFE) awarded Professional Doctorate in Policy Research and Practice honoris causa from University of Bath.
Published online first in the journal Neurology, a new study investigates the effectiveness of tools used to predict the recovery of patients after stroke.
Two articles published from the Nottingham Fatigue After Stroke (NOTFAST) study shed light on having fatigue six months after having a stroke.
Last week, our lecturers attended two training days at our head office, at Stroke Association House, London. These form part of a schedule of activity designed to ensure they have the skills, and support needed to succeed in becoming the next generation of research leaders.